EU's CVMP calls for more prudent use of newer cephalosporins in animals
This article was originally published in Scrip
Executive Summary
The EU's committee for medicinal products for veterinary use, the CVMP, "considers it wise" to take action to reduce the risk of animal use of third- and fourth-generation cephalosporins contributing to the emergence of resistance in human pathogens.